Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Haemophilia ; 20(1): e32-9, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24308756

RESUMO

Haemophilic arthropathy (HA) is characterized by chronic proliferative synovitis leading to cartilage destruction and shares some pathological features with rheumatoid arthritis (RA). Apoptosis has been implicated in RA pathogenesis, and an agonistic anti-Fas monoclonal antibody (mAb) was found to induce RA fibroblast-like synoviocyte (FLS) apoptosis and suppress synovial hyperplasia in animal models of RA. The aim of this study was to evaluate the effect of anti-Fas mAb on HA-FLS. FLS were isolated from knee synovial biopsies from six HA patients, six RA patients and six healthy subjects. The expression of Fas in synovial biopsies was investigated by immunohistochemistry. FLS were stimulated with anti-Fas mAb at different concentrations, alone or in combination with tumour necrosis factor-α (TNF-α) and basic fibroblast growth factor (bFGF). Fas expression in FLS was assessed by Western blot. Cell viability was studied with the WST-1 assay. Active caspase-3 levels were measured using ELISA and Western blot. A strong Fas-immunoreactivity was observed in different cells of HA synovium, including FLS, inflammatory cells and endothelial cells. Fas antigen was constitutively overexpressed in cultured HA-FLS. Anti-Fas mAb had a significant cytotoxicity on HA-FLS in a dose-dependent manner, either alone or in combination with TNF-α and bFGF. These cytotoxic effects were due to the ability of anti-Fas to induce HA-FLS apoptosis, as shown by the increased active caspase-3 levels. Anti-Fas mAb exhibited a more pronounced pro-apoptotic effect on HA-FLS than RA-FLS. Fas antigen is highly expressed on HA-FLS and its stimulation by anti-Fas mAb may be an effective strategy to induce HA-FLS apoptosis.


Assuntos
Anticorpos Monoclonais/farmacologia , Apoptose/efeitos dos fármacos , Fibroblastos/efeitos dos fármacos , Hemartrose/etiologia , Hemofilia A/complicações , Membrana Sinovial/efeitos dos fármacos , Membrana Sinovial/patologia , Adulto , Anticorpos Monoclonais/imunologia , Anticorpos Monoclonais Murinos , Artrite Reumatoide/metabolismo , Caspase 3/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Fibroblastos/metabolismo , Hemartrose/metabolismo , Hemartrose/patologia , Humanos , Imunoglobulina M/imunologia , Imunoglobulina M/farmacologia , Masculino , Pessoa de Meia-Idade , Membrana Sinovial/metabolismo , Adulto Jovem , Receptor fas/imunologia , Receptor fas/metabolismo
2.
Ann Rheum Dis ; 69(2): 458-61, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19336420

RESUMO

OBJECTIVE: Pregnant women with systemic sclerosis (SSc; scleroderma) have an increased risk of premature delivery and small full-term infants. During placental development, angiogenesis and vascular remodelling are essential for a successful pregnancy outcome. An analysis was made of the pathological changes and expression of angiogenic factors in SSc placentas. METHODS: Placenta biopsies were obtained from three patients with SSc and four healthy uncomplicated pregnancies after delivery at 34-38 weeks of gestation. The sections were stained with Masson's trichrome and phosphotungstic-acid-haematoxylin and immunostained for connective tissue growth factor (CTGF), alpha-smooth muscle actin (alpha-SMA), vascular endothelial growth factor (VEGF), placenta growth factor (PlGF) and receptors VEGFR-1 and VEGFR-2. RESULTS: The pathological findings were signs of decidual vasculopathy, increased syncytiotrophoblast knotting, placental infarcts and villous hypoplasia. Severe and diffuse perivascular and stromal fibrosis of decidua and chorionic villi, and extensive deposition of fibrinoid material around decidual vessels and in intervillous spaces were observed. Strong CTGF expression in the vessel wall, decidual cells and fibroblasts and alpha-SMA+ myofibroblasts were found. VEGF and VEGFR-2 expression was stronger in SSc than in healthy placentas, while VEGFR-1 expression was similar to controls. PlGF immunopositivity was weaker in SSc. CONCLUSION: In SSc placentas, severe fibrosis and abnormal vascular remodelling were detected. This may result in reduced blood flow leading to deep sufferance of maternal placenta and possible premature delivery.


Assuntos
Indutores da Angiogênese/metabolismo , Placenta/patologia , Complicações na Gravidez/metabolismo , Escleroderma Sistêmico/metabolismo , Actinas/metabolismo , Adulto , Biópsia , Fator de Crescimento do Tecido Conjuntivo/metabolismo , Feminino , Fibrose/etiologia , Humanos , Placenta/irrigação sanguínea , Placenta/metabolismo , Gravidez , Complicações na Gravidez/patologia , Escleroderma Sistêmico/complicações , Escleroderma Sistêmico/patologia
3.
Rheumatology (Oxford) ; 44(5): 607-13, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15728417

RESUMO

OBJECTIVE: Evidence shows that peripheral nervous system (PNS) is involved in systemic sclerosis (SSc), but few morphological studies have assessed the ultrastructural pathological modifications. The aim was to study ultrastructural modifications of skin PNS fibres in SSc according to subsets [limited SSc (lSSc) and diffuse SSc (dSSc)] and phases (early and advanced) of the disease. METHODS: Skin biopsies were taken from the forearms of 23 SSc patients (11 lSSc and 12 dSSc) and 10 controls. Each biopsy was processed for transmission electron microscopy (TEM). RESULTS: At TEM, observation in skin from early lSSc, signs of inflammation were evident, while PNS fibres were not damaged. The microvascular wall showed hypertrophic endothelial cells bulging into the lumen. In advanced lSSc, fibrosis prevailed on inflammation and slight ultrastructural alterations of PNS fibres were evident in the papillary derma. In early dSSc, ultrastructural alterations of PNS fibres, similar to those observed in the advanced phase of lSSc, were found together with signs of inflammation and fibrosis. In advanced dSSc, in the papillary and reticular dermis PNS fibres were reduced and showed relevant ultrastructural alterations. CONCLUSIONS: In SSc, PNS ultrastructure damage is linked to the progression and severity of skin involvement. The alterations evolve from the early to the advanced phase mainly in the diffuse subset. In particular, the severe PNS lesions found in advanced lSSc are already present and widely diffuse in early dSSc and the microvascular involvement in early lSSc seems to precede the modification of the PNS in the skin. Thus, an early therapeutic approach can be useful to reduce the progression of PNS and skin damage in SSc patients.


Assuntos
Doenças do Sistema Nervoso Periférico/etiologia , Escleroderma Sistêmico/complicações , Pele/inervação , Adulto , Biópsia , Progressão da Doença , Feminino , Humanos , Masculino , Microscopia Eletrônica de Transmissão , Pessoa de Meia-Idade , Doenças do Sistema Nervoso Periférico/patologia , Esclerodermia Difusa/etiologia , Esclerodermia Difusa/patologia , Esclerodermia Limitada/etiologia , Esclerodermia Limitada/patologia , Escleroderma Sistêmico/patologia , Pele/ultraestrutura
4.
Peptides ; 21(7): 985-93, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10998532

RESUMO

Nociceptin, a novel opioid peptide, and its ORL(1) receptor share structural similarities with other opioid ligands and receptors. Although NC exerts evident cardiovascular effects at a central and peripheral level, its role in homeostatic mechanisms and disease states are just beginning to be understood, as only recently selective receptor antagonists became available. In this review, some of the new observations regarding the cardiovascular actions of NC, related peptides and newly synthesized receptor antagonists are discussed.


Assuntos
Sistema Cardiovascular/metabolismo , Peptídeos Opioides/farmacologia , Peptídeos Opioides/fisiologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Encéfalo/metabolismo , Sistema Cardiovascular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Humanos , Canais Iônicos/metabolismo , Ligantes , Camundongos , Miocárdio/metabolismo , Peptídeos Opioides/antagonistas & inibidores , Peptídeos/farmacologia , Peptídeos/fisiologia , Fatores de Tempo , Vasodilatadores/farmacologia , Nociceptina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA